A Phase I/II Clinical Trial of Pomalidomide With Melphalan and Dexamethasone in Patients With Newly Diagnosed Untreated Systemic AL Amyloidosis: Trial Stopped During Phase I

Trial Profile

A Phase I/II Clinical Trial of Pomalidomide With Melphalan and Dexamethasone in Patients With Newly Diagnosed Untreated Systemic AL Amyloidosis: Trial Stopped During Phase I

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 25 May 2016

At a glance

  • Drugs Pomalidomide (Primary) ; Dexamethasone; Melphalan
  • Indications Amyloidosis
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Feb 2016 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
    • 15 Sep 2015 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Aug 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top